Zelnak AB - Search Results

1

The 21-gene recurrence score and locoregional recurrence in breast cancer patients.

Jegadeesh NK, Kim S, Prabhu RS, Oprea GM, Yu DS, Godette KG, Zelnak AB, Mister D, Switchenko JM, Torres MA. Jegadeesh NK, et al. Among authors: zelnak ab. Ann Surg Oncol. 2015 Apr;22(4):1088-94. doi: 10.1245/s10434-014-4252-y. Epub 2014 Dec 4. Ann Surg Oncol. 2015. PMID: 25472643 Free PMC article.

2

Endocrine therapy for the treatment of postmenopausal women with breast cancer.

Harichand-Herdt S, Zelnak A, O'Regan R. Harichand-Herdt S, et al. Expert Rev Anticancer Ther. 2009 Feb;9(2):187-98. doi: 10.1586/14737140.9.2.187. Expert Rev Anticancer Ther. 2009. PMID: 19192957 Review.

3

Clarifying the role of neoadjuvant therapy in breast cancer.

Zelnak A. Zelnak A. Oncology (Williston Park). 2010 Feb;24(2):149. Oncology (Williston Park). 2010. PMID: 20361465 Free article. No abstract available.

4

Improving on national quality indicators of breast cancer care in a large public hospital as a means to decrease disparities for African American women.

Rizzo M, Bumpers H, Okoli J, Senior-Crosby D, O'Regan R, Zelnak A, Pan L, Mosunjac M, Patterson SG, Gabram SG. Rizzo M, et al. Ann Surg Oncol. 2011 Jan;18(1):34-9. doi: 10.1245/s10434-010-1204-z. Epub 2010 Jul 13. Ann Surg Oncol. 2011. PMID: 20625838

5

Treatment adherence and outcome in women with inflammatory breast cancer: does race matter?

Andic F, Godette K, O'Regan R, Zelnak A, Liu T, Rizzo M, Gabram S, Torres M. Andic F, et al. Cancer. 2011 Dec 15;117(24):5485-92. doi: 10.1002/cncr.26187. Epub 2011 Jun 20. Cancer. 2011. PMID: 21692059 Free article.

6

21-Gene recurrence scores: racial differences in testing, scores, treatment, and outcome.

Lund MJ, Mosunjac M, Davis KM, Gabram-Mendola S, Rizzo M, Bumpers HL, Hearn S, Zelnak A, Styblo T, O'Regan RM. Lund MJ, et al. Cancer. 2012 Feb 1;118(3):788-96. doi: 10.1002/cncr.26180. Epub 2011 Jun 30. Cancer. 2012. PMID: 21720988 Free article.

7

The impact of skin-sparing mastectomy with immediate reconstruction in patients with Stage III breast cancer treated with neoadjuvant chemotherapy and postmastectomy radiation.

Prabhu R, Godette K, Carlson G, Losken A, Gabram S, Fasola C, O'Regan R, Zelnak A, Torres M. Prabhu R, et al. Int J Radiat Oncol Biol Phys. 2012 Mar 15;82(4):e587-93. doi: 10.1016/j.ijrobp.2011.09.024. Epub 2011 Dec 22. Int J Radiat Oncol Biol Phys. 2012. PMID: 22197232

8

Genomic subtypes in choosing adjuvant therapy for breast cancer.

Zelnak AB, O'Regan RM. Zelnak AB, et al. Oncology (Williston Park). 2013 Mar;27(3):204-10. Oncology (Williston Park). 2013. PMID: 23687790 Free article.

9

Special considerations in early-stage breast cancer patients and survivors.

Zelnak AB. Zelnak AB. Obstet Gynecol Clin North Am. 2013 Sep;40(3):573-82. doi: 10.1016/j.ogc.2013.05.007. Epub 2013 Jul 16. Obstet Gynecol Clin North Am. 2013. PMID: 24021258 Review.

10

Neoadjuvant Hormonal Therapy is Associated with Comparable Outcomes to Neoadjuvant Chemotherapy in Post-Menopausal Women with Estrogen Receptor-Positive Breast Cancer.

Marcus DM, Switchenko JM, Prabhu R, O'Regan R, Zelnak A, Fasola C, Mister D, Torres MA. Marcus DM, et al. Front Oncol. 2013 Dec 27;3:317. doi: 10.3389/fonc.2013.00317. eCollection 2013. Front Oncol. 2013. PMID: 24409418 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters